Skip to main content

Table 8 HSN distribution of proteins consistently expressed in cancer samples

From: Modelling human protein interaction networks as metric spaces has potential in disease research and drug target discovery

Type of cancer # proteins Zone 1 Zone 2 Zone 3 Zone 4 Zone 5 Zone 6
Breast 236 12 (5%) 151 (63.9%) 70 (29.6%) 2 (0.8%) 1 (0.4%) -
Cervical 533 42 (7.8%) 323 (60.6%) 157 (29.4%) 9 (1.6%) 1 (0.1%) 1 (0.1%)
Endometrial 1092 89 (8.1%) 647 (59.2%) 336 (30.7%) 17 (1.5%) 2 (0.1%) 1 (0.09%)
Fallopian 941 72 (7.6%) 563 (59.8%) 287 (30.4%) 16 (1.7%) 2 (0.2%) 1 (0.1%)
Glioblastoma 767 64 (8.3%) 471 (61.4%) 216 (28.1%) 13 (1.6%) 2 (0.2%) 1 (0.1%)
Glioma 824 35 (8%) 278 (64%) 114 (62.2%) 5 (1.1%) 1 (0.2%) 1 (0.2%)
Kidney 434 14 (2.4%) 331 (59%) 193 (34.4%) 23 (4%) - -
Liver 537 45 (8.3%) 328 (61%) 155 (28.8%) 7 (1.3%) 1 (0.1%) 1 (0.1%)
Lung 422 31 (7.3%) 260 (61.6%) 121 (28.6%) 8 (1.9%) 2 (0.4%) -
Ovarian 557 39 (7%) 334 (59.9%) 174 (31.2%) 8 (1.4%) 1 (0.1%) 1 (0.1%)
Pancreatic 536 46 (8.5%) 332 (61.9%) 148 (27.6%) 8 (1.4%) 1 (0.1%) 1 (0.1%)
Pituitary 789 56 (7%) 458 (58%) 253 (32%) 19 (2.4%) 2 (0.2%) 1 (0.1%)
Rectal 1162 95 (8.1%) 677 (58.2%) 365 (31.4%) 21 (1.8%) 3 (0.2%) 1 (0.8%)
Average   7.5% 60.6% 29.6% 1.5% 0.2% 0.1%